000 03146nam a22004095i 4500
999 _c394584
_d394584
001 394584
003 ES-MaUEC
005 20230103135619.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 220630s2022 sz | s |||| 0|eng d
020 _a9783030946586
024 7 _a10.1007/978-3-030-94658-6
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC400
_b2022 EB
100 1 _aSchultheiss, Timothy E.,
_9685854
_d1951-
245 1 0 _aRadiation Myelopathy
_cby Timothy Schultheiss
250 _a1st edition 2022
264 1 _aCham
_bSpringer International Publishing,
_c2022
300 _a1 recurso en línea (XXVI, 240 páginas)
_b55 ilustraciones, 26 ilustraciones a color
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
505 0 _aHistory -- Pathogenesis of radiation myelopathy -- Clinical radiation myelopathy -- Radiation myelopathy in stereotactic radiosurgery -- Experimental studies on fractionation effects -- Experimental studies on volume effects -- Other clinical and experimental studies -- Multispecies dose response model -- Treatment of myelopathy -- Medico-legal issues.
520 _aThis book covers every aspect of radiation myelopathy and considers the evidence from all species in which it has been studied. The historical and current understanding of the pathogenesis of this rare but devastating injury is first discussed. The evidence regarding the role of a variety of factors in radiation myelopathy is then reviewed. Readers will find detailed information on the impacts of total radiation dose, radiation volume, dose fractionation, hyper fractionation, age, anatomic level, comorbidities, radiation modifiers, other therapies, and retreatment of the spinal cord. Given the similarity of the pathogenesis of radiation myelopathy in humans and experimental animals, the potential for cross-species modelling of dose response is explored, with attention to relevant species differences. Treatment of the condition is also fully considered. New theories are presented regarding retreatment, small volume response, and the final step in white matter necrosis. The final chapter addresses the medicolegal issues elicited by radiation myelopathy, which is often the result of treatment error. Radiation Myelopathy will be of high value for radiation oncologists, radiation physicists, dosimetrists, biologists, neurologists, medical oncologists, and attorneys.
988 _aSpringer_Medicine_2022
650 7 _2embne
_9168935
_aMédula espinal
_xEnfermedades
776 0 8 _iPrinted edition:
_z9783030946579
776 0 8 _iPrinted edition:
_z9783030946593
776 0 8 _iPrinted edition:
_z9783030946609
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-94658-6
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b12/2022
_dz
_eh
_zSI